CTRI/2021/09/036689尚未招募未知
tility of Pentraxin-3 and Presepsin in prognosis of sepsis in critically ill patients - 3P in Sepsis
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adult patients having clinical features suggestive of sepsis
排除标准
- •Exclusion criteria are age < 18 years, patients with terminal stage of disease (malignant cancer of any type, acquired immunodeficiency syndrome, end-stage liver or renal disease) patient who have received antibiotics and patient/relatives who will not consent to inclusion.
研究者
相似试验
已完成
不适用
The diagnostic utility of Pentraxin 3 for predicting activity in patients with glomerulonephritisglomerulonephritisJPRN-UMIN000011583Kobe University Graduate School of Medicine, Division of Nephrology & Kidney Center90
已完成
不适用
Association between plasma pentraxin-3 levels and risk of all-cause mortality in Japanese hemodialysis patients with nutritional riskEnd stage kidney diseaseJPRN-UMIN000016190Second Department of Internal Medicine, University of Occupational and Environmental Health383
已完成
不适用
The Clinical Significance of Plasma Pentraxin 3 levels for Patients with Diastolic Heart FailurePatients with heart failureJPRN-UMIN000002170Graduate School of Medical Sciences, Kumamoto University200
Unknown
不适用
Diagnostic and Prognostic Utility of Pentraxin 3 in Patients With Acute STEMI Undergoing Primary PCIMyocardial InfarctionNCT03476252Assiut University100
已完成
不适用
Preeclamptic Patients and Pentraxin 3 & Lipoprotein-associated Phospholipase A2Pre-EclampsiaNCT04239352Kanuni Sultan Suleyman Training and Research Hospital80